SI2315597T1 - Novi sestavki in postopki - Google Patents

Novi sestavki in postopki

Info

Publication number: SI2315597T1
Authority: SI; Slovenia
Prior art keywords: methods; novel compositions; compositions; novel
Prior art date: 2008-07-25

Application number

SI200931748T

Other languages

English (en)

Inventor

James Brown

Pascal Mettens

Dennis Murphy

Original Assignee

Glaxosmithkline Biologicals S.A.

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-25

Filing date

2009-07-24

Publication date

2017-12-29

2009-07-24 Application filed by Glaxosmithkline Biologicals S.A., Glaxo Group Limited filed Critical Glaxosmithkline Biologicals S.A.

2017-12-29 Publication of SI2315597T1 publication Critical patent/SI2315597T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Mycology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biotechnology (AREA)
Analytical Chemistry (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Tropical Medicine & Parasitology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Virology (AREA)
Cell Biology (AREA)
Oncology (AREA)

SI200931748T 2008-07-25 2009-07-24 Novi sestavki in postopki SI2315597T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US8369208P	2008-07-25	2008-07-25
PCT/EP2009/059586 WO2010010180A1 (en)	2008-07-25	2009-07-24	Novel compositions and methods
EP09781058.4A EP2315597B1 (en)	2008-07-25	2009-07-24	Novel compositions and methods

Publications (1)

Publication Number	Publication Date
SI2315597T1 true SI2315597T1 (sl)	2017-12-29

Family

ID=41172233

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200931748T SI2315597T1 (sl)	2008-07-25	2009-07-24	Novi sestavki in postopki

Country Status (24)

Country	Link
US (2)	US9315556B2 (sl)
EP (1)	EP2315597B1 (sl)
JP (1)	JP5824360B2 (sl)
KR (2)	KR20160013262A (sl)
CN (2)	CN102164612B (sl)
AU (1)	AU2009273133B2 (sl)
BR (1)	BRPI0916705A2 (sl)
CA (1)	CA2731549C (sl)
CO (1)	CO6400198A2 (sl)
CY (1)	CY1119737T1 (sl)
EA (1)	EA022203B1 (sl)
ES (1)	ES2647321T3 (sl)
HR (1)	HRP20171694T1 (sl)
HU (1)	HUE037121T2 (sl)
IL (1)	IL210588A0 (sl)
LT (1)	LT2315597T (sl)
MX (1)	MX2011000981A (sl)
NO (1)	NO2315597T3 (sl)
PL (1)	PL2315597T3 (sl)
PT (1)	PT2315597T (sl)
SG (1)	SG10201505149WA (sl)
SI (1)	SI2315597T1 (sl)
UA (1)	UA107180C2 (sl)
WO (1)	WO2010010180A1 (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0916704A2 (pt)	2008-07-25	2020-08-18	Glaxosmithkline Biologicals S.A.	composições farmacêutica, e imunogênica, usos de um polipeptídeo, e de um polinucleotídeo, proteína de fusão, e, polinucleotídeo
GB201116248D0 (en)	2011-09-20	2011-11-02	Glaxosmithkline Biolog Sa	Liposome production using isopropanol
WO2013090897A1 (en) *	2011-12-15	2013-06-20	The Trustees Of The University Of Pennsylvania	Using adaptive immunity to detect drug resistance
CN103467582A (zh) *	2012-06-08	2013-12-25	同济大学	结核杆菌重要抗原的高通量筛选及其在结核病诊断中的应用
GB201405921D0 (en) *	2014-04-02	2014-05-14	Glaxosmithkline Biolog Sa	Novel methods for inducing an immune response
EP3551222B1 (en)	2016-12-07	2024-08-07	GlaxoSmithKline Biologicals SA	Process for making a liposome composition comprising a saponin
GB201621686D0 (en)	2016-12-20	2017-02-01	Glaxosmithkline Biologicals Sa	Novel methods for inducing an immune response
GB201707700D0 (en)	2017-05-12	2017-06-28	Glaxosmithkline Biologicals Sa	Dried composition
CA3063954A1 (en)	2017-05-30	2018-12-06	Glaxosmithline Biologicals S.A.	Methods for manufacturing an adjuvant
WO2019106192A1 (en)	2017-12-01	2019-06-06	Glaxosmithkline Biologicals Sa	Saponin purification
WO2020214961A1 (en) *	2019-04-17	2020-10-22	Codiak Biosciences, Inc.	Methods of treating tuberculosis
EP3980044A1 (en)	2019-06-05	2022-04-13	GlaxoSmithKline Biologicals SA	Saponin purification

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4016146A (en) *	1974-12-10	1977-04-05	Biological Developments, Inc.	Phenethylamine antigenic conjugates, their preparation, antibodies, and use
UA40597C2 (uk)	1992-06-25	2001-08-15	Смітклайн Бічем Байолоджікалс С.А.	Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
US6458366B1 (en)	1995-09-01	2002-10-01	Corixa Corporation	Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en)	1995-09-01	2003-07-15	Corixa Corporation	Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6613881B1 (en)	1997-05-20	2003-09-02	Corixa Corporation	Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
US7087713B2 (en) *	2000-02-25	2006-08-08	Corixa Corporation	Compounds and methods for diagnosis and immunotherapy of tuberculosis
NZ507378A (en)	1998-04-07	2002-12-20	Corixa Corp	Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6291013B1 (en) *	1999-05-03	2001-09-18	Southern Biosystems, Inc.	Emulsion-based processes for making microparticles
WO2001019993A2 (en)	1999-09-17	2001-03-22	University Of Maryland, Baltimore	Virulence genes of m. marinum and m. tuberculosis
US7311922B1 (en)	1999-10-07	2007-12-25	Corixa Corporation	Fusion proteins of mycobacterium tuberculosis
EP2133100B1 (en)	2000-06-20	2011-10-05	Corixa Corporation	MTB32A Antigen of mycobacterium tuberculosis with inactivated active site and fusion proteins thereof
CN1277843C (zh)	2001-02-22	2006-10-04	巴斯德研究院	分枝杆菌比较基因组学作为鉴定分枝杆菌病的诊断、预防或治疗靶的工具
US7026465B2 (en)	2002-02-15	2006-04-11	Corixa Corporation	Fusion proteins of Mycobacterium tuberculosis
US20030236393A1 (en) *	2002-03-22	2003-12-25	United States Of America Dept Of Vetrans Affairs	Virulence genes of M. marinum and M. tuberculosis
EP1721283B1 (en) *	2004-02-06	2022-11-30	Council of Scientific and Industrial Research	Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
AU2006243357B2 (en) *	2005-04-29	2012-03-15	Glaxosmithkline Biologicals S.A.	Novel method for preventing or treating M tuberculosis infection
WO2008007942A1 (en)	2006-07-10	2008-01-17	Het Nederlands Kanker Instituut	Means and methods for manipulating sequential phagolysomal-cytosolic translocation of mycobacteria, and uses thereof
EA021391B1 (ru)	2007-03-02	2015-06-30	Глаксосмитклайн Байолоджикалс С.А.	Способ индукции иммунного ответа, вакцинная композиция, ее применение и набор
BRPI0916704A2 (pt) *	2008-07-25	2020-08-18	Glaxosmithkline Biologicals S.A.	composições farmacêutica, e imunogênica, usos de um polipeptídeo, e de um polinucleotídeo, proteína de fusão, e, polinucleotídeo
AU2009273130B2 (en) *	2008-07-25	2014-10-16	Glaxo Group Limited	Novel compositions and methods
WO2010010178A1 (en)	2008-07-25	2010-01-28	Glaxosmithkline Biologicals S.A	The tuberculosis rv2707c protein, compositions and uses thereof
CN104107425B (zh)	2009-04-24	2018-07-17	国家血清研究所	预防再激活的结核病tb疫苗
WO2010132112A2 (en)	2009-05-14	2010-11-18	Wisconsin Alumni Research Foundation	Immunogenic compositions against tuberculosis
HUE031184T2 (en)	2010-01-27	2017-06-28	Glaxosmithkline Biologicals Sa	Modified tuberculosis antigens

2009
- 2009-07-24 EA EA201100071A patent/EA022203B1/ru not_active IP Right Cessation
- 2009-07-24 SI SI200931748T patent/SI2315597T1/sl unknown
- 2009-07-24 US US13/055,775 patent/US9315556B2/en active Active
- 2009-07-24 CN CN200980138416.7A patent/CN102164612B/zh active Active
- 2009-07-24 LT LTEP09781058.4T patent/LT2315597T/lt unknown
- 2009-07-24 EP EP09781058.4A patent/EP2315597B1/en active Active
- 2009-07-24 UA UAA201100362A patent/UA107180C2/uk unknown
- 2009-07-24 SG SG10201505149WA patent/SG10201505149WA/en unknown
- 2009-07-24 PL PL09781058T patent/PL2315597T3/pl unknown
- 2009-07-24 MX MX2011000981A patent/MX2011000981A/es active IP Right Grant
- 2009-07-24 AU AU2009273133A patent/AU2009273133B2/en not_active Ceased
- 2009-07-24 WO PCT/EP2009/059586 patent/WO2010010180A1/en active Application Filing
- 2009-07-24 BR BRPI0916705A patent/BRPI0916705A2/pt not_active Application Discontinuation
- 2009-07-24 PT PT97810584T patent/PT2315597T/pt unknown
- 2009-07-24 JP JP2011519187A patent/JP5824360B2/ja active Active
- 2009-07-24 ES ES09781058.4T patent/ES2647321T3/es active Active
- 2009-07-24 CA CA2731549A patent/CA2731549C/en active Active
- 2009-07-24 KR KR1020167001375A patent/KR20160013262A/ko not_active Application Discontinuation
- 2009-07-24 KR KR1020117004475A patent/KR20110060891A/ko not_active Application Discontinuation
- 2009-07-24 NO NO09781058A patent/NO2315597T3/no unknown
- 2009-07-24 CN CN201711306994.XA patent/CN108059660A/zh active Pending
- 2009-07-24 HU HUE09781058A patent/HUE037121T2/hu unknown
2011
- 2011-01-12 IL IL210588A patent/IL210588A0/en unknown
- 2011-01-27 CO CO11009236A patent/CO6400198A2/es not_active Application Discontinuation
2016
- 2016-03-11 US US15/067,469 patent/US9750794B2/en active Active
2017
- 2017-11-06 HR HRP20171694TT patent/HRP20171694T1/hr unknown
- 2017-11-13 CY CY20171101185T patent/CY1119737T1/el unknown

Also Published As

Publication number	Publication date
AU2009273133A1 (en)	2010-01-28
PT2315597T (pt)	2017-11-20
HUE037121T2 (hu)	2018-08-28
CN102164612B (zh)	2018-01-16
CY1119737T1 (el)	2018-06-27
CA2731549C (en)	2018-07-17
AU2009273133B2 (en)	2014-06-05
KR20160013262A (ko)	2016-02-03
US20160184420A1 (en)	2016-06-30
CO6400198A2 (es)	2012-03-15
IL210588A0 (en)	2011-03-31
WO2010010180A1 (en)	2010-01-28
KR20110060891A (ko)	2011-06-08
PL2315597T3 (pl)	2018-01-31
LT2315597T (lt)	2018-02-12
US20110223200A1 (en)	2011-09-15
SG10201505149WA (en)	2015-07-30
EA201100071A1 (ru)	2011-10-31
HRP20171694T1 (hr)	2017-12-15
ES2647321T3 (es)	2017-12-20
US9315556B2 (en)	2016-04-19
EA022203B1 (ru)	2015-11-30
MX2011000981A (es)	2011-03-02
CA2731549A1 (en)	2010-01-28
US9750794B2 (en)	2017-09-05
JP2011528897A (ja)	2011-12-01
JP5824360B2 (ja)	2015-11-25
EP2315597A1 (en)	2011-05-04
EP2315597B1 (en)	2017-08-23
UA107180C2 (uk)	2014-12-10
CN102164612A (zh)	2011-08-24
BRPI0916705A2 (pt)	2015-11-10
CN108059660A (zh)	2018-05-22
NO2315597T3 (sl)	2018-01-20

Publication	Publication Date	Title
IL210153A0 (en)	2011-03-31	Nutrigenomics methods and compositions
IL212822A0 (en)	2011-07-31	Anti-cxcr1 compositions and methods
GB0815872D0 (en)	2008-10-08	Novel method and compositions
ZA201001300B (en)	2010-11-24	Antigen-asjuvant compositions and methods
PL2137210T3 (pl)	2017-06-30	Nowy sposób i kompozycje
GB0819530D0 (en)	2008-12-03	Methods and compositions
PL3812360T3 (pl)	2024-04-08	Związki monochlorotrifluoropropenu oraz kompozycje i sposoby ich zastosowania
EP2334804A4 (en)	2012-05-23	COCULTURAL COMPOSITIONS AND METHODS
IL210559A0 (en)	2011-03-31	Novel compositions and methods
IL210588A0 (en)	2011-03-31	Novel compositions and methods
GB0817585D0 (en)	2008-11-05	Novel compositions and methods
GB0721291D0 (en)	2007-12-12	Methods and compositions
GB0809912D0 (en)	2008-07-09	Novel compositions and uses thereof
GB0719526D0 (en)	2007-11-14	Compositions and methods
GB0901494D0 (en)	2009-03-11	Compositions and Methods
SI2320888T1 (sl)	2014-02-28	Sestavki laidlomicina in postopki
GB0811250D0 (en)	2008-07-30	Methods and compositions
GB0816534D0 (en)	2008-10-15	Compositions and methods
GB0811152D0 (en)	2008-07-23	Methods and compositions
GB0803464D0 (en)	2008-04-02	Methods and compositions
GB0818399D0 (en)	2008-11-12	Methods and compositions
GB0802079D0 (en)	2008-03-12	Method and compositions
GB0723775D0 (en)	2008-01-16	Methods and compositions
GB0724549D0 (en)	2008-01-30	Compositions and methods
GB0717683D0 (en)	2007-10-17	Compositions and methods